Skip to content
10-Q

Quarterly Report

APTEVO THERAPEUTICS INC. APVO

0001193125-25-269598

← back to feed
Filed
Nov 6, 2025 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Nov 6, 2025 16.85M sh
Shares Diluted Q3 2025 · Sep 30, 2025 4.05M sh
Shares Diluted Q3 2025 · Sep 30, 2025 1.9M sh
Shares Diluted restated Q3 2025 · Sep 30, 2024 14.25K sh
Shares Diluted restated Q3 2025 · Sep 30, 2024 4.8K sh
Operating Cash Flow Q3 2025 · Sep 30, 2025 −$20.36M
Operating Cash Flow Q3 2025 · Sep 30, 2024 −$18.03M
Cash And Equivalents Q3 2025 · Sep 30, 2025 $21.06M
Cash And Equivalents Q3 2025 · Dec 31, 2024 $8.71M
Cash And Equivalents Q3 2025 · Sep 30, 2024 $7.75M
Stockholders Equity Q3 2025 · Sep 30, 2025 $17.39M
Stockholders Equity Q3 2025 · Jun 30, 2025 $6.52M
Stockholders Equity Q3 2025 · Mar 31, 2025 −$1.47M
Stockholders Equity Q3 2025 · Dec 31, 2024 $4.76M
Stockholders Equity Q3 2025 · Sep 30, 2024 $4.42M
Stockholders Equity Q3 2025 · Jun 30, 2024 $4.46M
Stockholders Equity Q3 2025 · Mar 31, 2024 $6.1M
Stockholders Equity Q3 2025 · Dec 31, 2023 $12.22M
Current Liabilities Q3 2025 · Sep 30, 2025 $5.61M
Current Liabilities Q3 2025 · Dec 31, 2024 $6.21M
Total Liabilities Q3 2025 · Sep 30, 2025 $9.6M
Total Liabilities Q3 2025 · Dec 31, 2024 $10.84M
Current Assets Q3 2025 · Sep 30, 2025 $22.65M
Current Assets Q3 2025 · Dec 31, 2024 $10.66M
Total Assets Q3 2025 · Sep 30, 2025 $27M
Total Assets Q3 2025 · Dec 31, 2024 $15.59M
Eps Diluted Q3 2025 · Sep 30, 2025 −$2.23
Eps Diluted Q3 2025 · Sep 30, 2025 −$11.42
Eps Diluted restated Q3 2025 · Sep 30, 2024 −$357.86
Eps Diluted restated Q3 2025 · Sep 30, 2024 −$3,709.76
Eps Basic Q3 2025 · Sep 30, 2025 −$2.23
Eps Basic Q3 2025 · Sep 30, 2025 −$11.42
Eps Basic restated Q3 2025 · Sep 30, 2024 −$357.86
Eps Basic restated Q3 2025 · Sep 30, 2024 −$3,709.76
Rd Expense Q3 2025 · Sep 30, 2025 $4.04M
Rd Expense Q3 2025 · Sep 30, 2025 $11.01M
Rd Expense Q3 2025 · Sep 30, 2024 $3.1M
Rd Expense Q3 2025 · Sep 30, 2024 $10.5M
Net Income Q3 2025 · Sep 30, 2025 −$7.55M
Net Income Q3 2025 · Sep 30, 2025 −$20.16M
Net Income Q3 2025 · Jun 30, 2025 −$6.2M
Net Income Q3 2025 · Mar 31, 2025 −$6.41M
Net Income Q3 2025 · Sep 30, 2024 −$5.1M
Net Income Q3 2025 · Sep 30, 2024 −$17.82M
Net Income Q3 2025 · Jun 30, 2024 −$5.88M
Net Income Q3 2025 · Mar 31, 2024 −$6.83M
Operating Income Q3 2025 · Sep 30, 2025 −$7.61M
Operating Income Q3 2025 · Sep 30, 2025 −$20.32M
Operating Income Q3 2025 · Sep 30, 2024 −$5.21M
Operating Income Q3 2025 · Sep 30, 2024 −$18.22M